Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06102395
Status:
RECRUITING
Last Update Posted:
2023-10-30
First Post:
2023-04-12
Brief Title:
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced LA HNSCC
Sponsor:
Beijing Tongren Hospital
Organization:
Beijing Tongren Hospital
Organization Data
Organization:
Beijing Tongren Hospital
Class:
OTHER
Study ID:
NCT23456
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Tongren Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None